[1]阿依努·艾力 布威阿依谢姆·努尔麦麦提 阿迪拉·阿扎提 迪丽达尔·希力甫.雌雄性大鼠高尿酸血症动物模型的动态比较[J].心血管病学进展,2023,(3):277.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.019]
　Aynur·Aili,Buviayxem·Nurmamat,Adila·Azat,et al.Dynamic Comparison of Hyperuricemia Animal Model in Male and Female Rats[J].Advances in Cardiovascular Diseases,2023,(3):277.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.019]
点击复制

雌雄性大鼠高尿酸血症动物模型的动态比较()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年3期
页码:
277
栏目:
论著
出版日期:
2023-03-25

文章信息/Info

Title:
Dynamic Comparison of Hyperuricemia Animal Model in Male and Female Rats
作者:
阿依努·艾力 布威阿依谢姆·努尔麦麦提1 阿迪拉·阿扎提1 迪丽达尔·希力甫2
(1.新疆医科大学第一临床学院,新疆 乌鲁木齐 83;2.新疆医科大学第一附属医院心脏中心,新疆 乌鲁木齐 83)
Author(s):
Aynur·Aili1; Buviayxem·Nurmamat1; Adila·Azat1; Dildar·Xerip2
(1. The First Clinical College of Xinjiang Medical University ,Urumqi 830011,Xinjiang,China; 2.Heart Center of The First Affiliated Hospital of Xinjiang Medical University ,Urumqi 830011,Xinjiang,China)
关键词:
高尿酸血症; 动物模型; 酵母膏; 氧嗪酸钾; 雄性大鼠
Keywords:
Hyperuricemia; Animal models; Yeast extract; Oxonic acid potassium; Male rats
DOI:
10.16806/j.cnki.issn.1004-3934.2023.03.019
摘要:
目的 采用酵母膏联合氧嗪酸钾构建雌性大鼠和雄性大鼠高尿酸模型，观察持续高尿酸血症对雌雄性大鼠血清生化及心、肾脏、尾动脉和主动脉的病理改变的影响。方法 以酵母膏21 gg·d)给予喂养，氧嗪酸钾以200 mgg·d)持续腹腔注射28 d建立高尿酸血症雌雄性大鼠模型。结果 酵母膏21 gg·d)喂养联合氧嗪酸钾200 mgg·d)持续腹腔注射28 d，雌性大鼠血清尿酸水平可维持在更高水平，高血清尿酸水平使大鼠心脏、肾脏动脉也发生了一系列病理改变，且雌性大鼠病理改变较雄性大鼠明显。结论 雌性大鼠的造模效果优于雄性大鼠，应为建立高尿酸血症动物模型的首要选择。
Abstract:
Objective Using yeast extract combined with oxonic acid potassium to construct hyperuric acid model of female and male rats,to observe the effect of persistent hyperuricemia on serum indexes and pathological changes of heart,kidney,tail artery and aorta in female and male rats. Methods Feeding yeast extract 21 g/(kg·d), and oxonic acid potassium was continuously injected intraperitoneally for 28 days at 200 mg/(kg·d) to establish the female and male models of hyperuricemia. Results Yeast extract 21 g/(kg·d) feeding combined with oxonic acid potassium 200 mg/(kg·d) continuous intraperitoneal injection for 28 days,the serum uric acid level of female rats can maintain at a higher level,and the high serum uric acid level also causes a series of pathological changes in the heart,kidney and arteries of rats,and the pathological changes of female rats are more obvious than that of male rats. Conclusion The modeling effect of female rats is better than that of male rats,which should be the first choice to establish the animal model of hyperuricemia.

参考文献/References:

[1].Wu J,Qiu L,Cheng XQ,et al. Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population[J]. Sci Rep,2017,7(1):5456.
[2].孙珊珊,曲连悦,杜荣蓉,等. 高尿酸血症药物治疗研究进展[J]. 中国临床药理学与治疗学, 2019,24(5):589-594.
[3].嗪酸钾构建高尿酸血症模型大鼠继发的心血管病变[J]. 中国组织工程研究,2012,16(11):1994-1998.
[4].Bardin T,Richette P. Definition of hyperuricemia and gouty conditions[J]. Curr Opin Rheumatol,2014,26(2):186-191．
[5].张静,田倩雯,侯仕强,等. 性别差异对小鼠抗原诱导型干燥综合征模型的影响[J/OL]. 中国药理学通报,2022(9):1435-1440.
[6].Nishizawa H,Maeda N,Shimomura I,et al. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease[J]. Hypertens Res,2022,45(4):635-640.
[7].Jaffe DH,Klein AB,Benis A,et al. Incident gout and chronic kidney disease:healthcare utilization and survival[J]. BMC Rheumatol,2019,3:11.
[8].Oda M,Satta Y,Takenaka O,et al. Loss of urate oxidase activity in hominoids and its evolutionary implications[J]. Mol Biol Evol,2002,19(5):640-653.
[9].Mandal AK,Mount DB. The molecular physiology of uric acid homeostasis[J]. Annu Rev Physiol,2015,77:323-345.
[10].邹筱芳,巫冠中. 尿酸肾损伤的分子机制研究进展[J]. 安徽医药,2015,19(1):5-9.
[11].Singh JA,Cleveland JD. Gout and the risk of incident atrial fibrillation in older adults:a study of US Medicare data[J]. RMD Open,2018,4(2):e000712.
[12].Chen-Xu M,Yokose C,Rai SK,et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends:the National Health and Nutrition Examination Survey,2007-2016[J]. Arthritis Rheumatol,2019,71(6):991-999.
[13].Dalbeth N,Choi HK,Joosten LAB. Gout[J]. Nat Rev Dis Primers,2019,5(1):69.
[14].Li N,Zhang S,Li W,et al. Prevalence of hyperuricemia and its related risk factors among preschool children from China[J]. Sci Rep,2017,7(1):439-445.
[15].Wang CP,Wang Y,Wang X,et al. Mulberroside a possesses potent uricosuric andnephroprotective effects in hyperuricemic mice[J]. Planta Med,2011,77(8):786-794.
[16].Sattui SE,Gaffo AL. Treatment of hyperuricemia in gout:current therapeutic options,latest developments and clinical implications[J]. Ther Adv Musculoskelet Dis,2016,8(4):145-159．
[17].陈林军,杨焱,吴迪,等. 高尿酸血症及并其发症大鼠模型的建立[J]. 中国实验动物学报,2020,28(4):510-516.
[18].姬志祥,蓝常贡. 尿酸盐转运蛋白在痛风中的多态性和治疗相关性[J]. 中国组织工程研究,2020,25(8):1290-1298.
[19].Martillo MA,Nazzal L,Crittenden DB. The crystallization of monosodium urate[J]. Curr Rheumatol Rep,2014,16(2):400.
[20].Bahadoran Z,Mirmiran P,Kashfi K,et al. Hyperuricemia-induced endothelial insulin resistance:the nitric oxide connection[J]. Pflugers Arch,2022,474(1):83-98.
[21].刘冬恋,郭秋鸿,夏阳淼,等. 慢性高尿酸血症肾损害大鼠模型的建立[J]. 中国实验动物学报,2021,29(3):364-370.
[22].Wu AH,Gladden JD,Ahmed M,et al. Relation of serum uric acid to cardiovascular disease[J]. Int J Cardiol,2016,213:4-7.
[23].丁畅,吴晓馗,汤涌. 别嘌醇对合并高尿酸血症的慢性心力衰竭患者心功能的影响[J]. 黑龙江医学,2009,33(1):19-20.
[24].杨丽. 糖肾康对DN模型大鼠血中ICAM-1、MCP-1的影响及其对气阴两虚血瘀证DN 患者的治疗作用[D]. 安徽中医药大学, 2016.

相似文献/References:

[1]周颖 顾宁.基于高尿酸血症与高血压相关性的药物研究进展[J].心血管病学进展,2020,(6):630.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.017]
　ZHOU Ying,GU Ning.Drugs Based on the Relationship Between Hyperuricemia and Hypertension[J].Advances in Cardiovascular Diseases,2020,(3):630.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.017]
[2]高可 杨蕾 姚新叶 郑小璞.射血分数保留性心力衰竭动物模型的研究进展[J].心血管病学进展,2020,(8):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
　GAO Ke,YANG Lei,YAO Xinye,et al.Advances in Animal Models ofHeart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(3):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
[3]蔺雅娟 杨晓蕾 夏云龙.不同尿酸水平与心血管疾病之间的关系[J].心血管病学进展,2020,(9):911.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.006]
　LIN Yajuan,YANG Xiaolei,XIA Yunlong.The Relationship Between Different Levels of Uric Acid and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(3):911.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.006]
[4]周玲梅 张文倩 张智伟.体-肺动脉分流术在建立先天性心脏病动物模型中的应用进展[J].心血管病学进展,2021,(7):628.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.013]
　ZHOU Lingmei,ZHANG Wenqian,ZHANG Zhiwei.Application Progress of Systemic Pulmonary Arterial Shunt in Animal Model of Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2021,(3):628.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.013]
[5]叶鹏飞 郭应坤 张怡 沈梦婷 李湘 陈林 徐婷 文凌仪.动脉粥样硬化斑块磁共振成像动物模型[J].心血管病学进展,2021,(8):730.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.014]
　YE Pengfei,GUO Yingkun,ZHANG Yi,et al.Animal Models for Magnetic Resonance Imaging of Atherosclerotic Plaque[J].Advances in Cardiovascular Diseases,2021,(3):730.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.014]
[6]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
　WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[7]游月婷 黄刚 张小刚 张亚丽 邓自刚 屈树新 靳忠民 徐俊波.心力衰竭动物建模的进展[J].心血管病学进展,2021,(12):1105.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.012]
　YOU YuetingHUANG Gang,ZHANG Xiaogang,ZHANG Yali,et al.Animal Models Establishment of Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):1105.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.012]
[8]胡美曦 黄志华 柳志红 赵智慧 罗勤 赵青.慢性血栓栓塞性肺动脉高压：构建动物模型的研究进展[J].心血管病学进展,2022,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
　HU Meixi,HUANG Zhihua,LIU Zhihong,et al.Chronic Thromboembolic Pulmonary Hypertension: Advances in Constructing Animal Models[J].Advances in Cardiovascular Diseases,2022,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[9]卢燕 刘亚萍 罗强 张全波 汪汉.肠道菌群及其代谢物与痛风[J].心血管病学进展,2023,(2):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
　LU Yan,LIU Yaping,LUO Qiang,et al.Intestinal Flora and Its Metabolites and Gout[J].Advances in Cardiovascular Diseases,2023,(3):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]

备注/Memo

备注/Memo:
基金项目：新疆维吾尔自治区域协同创新专项-上海合作组织科技伙伴计划及国际科技合作项目（22E01037）
更新日期/Last Update: 2023-04-24